According to the World Health Organization, 74% of all deaths worldwide (41 million) are from chronic, non-communicable diseases. The majority of such diseases, however, lack critical funding or effective therapies, which is in particular the case in low- and middle-income countries where more than three-quarters of the deaths occur.
At the Institute for Life Sciences Collaboration (ILSC), we believe that collaboration and innovation are the best ways to achieve a world free of underfunded non-communicable diseases. To make the greatest possible impact, ILSC applies its expertise and resources in areas of therapeutics, diagnostics, and research.
Make a measurable global impact on non-communicable diseases through therapeutics, diagnostics, and research
Alleviate health suffering and extend life expectancies